Therapy Areas: Respiratory
Hikma launches TYZAVAN in US
9 December 2025 - UK-based multinational pharmaceutical company Hikma Pharmaceuticals plc (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) announced on Monday that it has introduced the first-of-its-kind, ...
PureTech clears key FDA milestone for Phase 3 development of deupirfenidone
8 December 2025 - Biotherapeutics company PureTech Health plc (Nasdaq: PRTC) (LSE: PRTC) has completed a successful End-of-Phase 2 meeting with the U.S. Food and Drug Administration for deupirfenidone...
DELFI Diagnostics presents preliminary data showing potential for blood-based lung cancer detection in non-smoking population
8 December 2025 - DELFI Diagnostics Inc, a developer of accessible blood-based, liquid biopsy tests for early cancer detection, on Friday announced the presentation of preliminary data from the Female...
Orano Med and Roche advance pretargeted radioimmunotherapy into clinical phase
4 December 2025 - Orano Med, a subsidiary of the Orano group with a focus on nuclear medicine, announced on Thursday that its collaboration with Swiss biotechnology company Roche (SIX: RO, ROG; OTCQX:...
bioMérieux launches equine endocrinology tests to expand point-of-care diagnostics
4 December 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Thursday that it has introduced two equine endocrinology immunoassays -- VIDAS Equine INSULIN and VIDAS...
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
4 December 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) confirmed on Thursday that it has completed its acquisition of UK biotechnology company Vicebio Ltd, adding an...